LSU Biomedical Research Center: Two Popular Diabetes Drugs Outperformed Others In Large Clinical Trial
October 07, 2022
October 07, 2022
BATON ROUGE, Louisiana, Oct. 7 (TNSjou) -- The Louisiana State University's Pennington Biomedical Research Center issued the following news release:
In a large clinical trial that directly compared four drugs commonly used to treat type 2 diabetes, researchers found that insulin glargine and liraglutide performed the best of four medications approved by the U.S. Food and Drug Administration to maintain blood glucose levels in the recommended range. Blood glucose management is a . . .
In a large clinical trial that directly compared four drugs commonly used to treat type 2 diabetes, researchers found that insulin glargine and liraglutide performed the best of four medications approved by the U.S. Food and Drug Administration to maintain blood glucose levels in the recommended range. Blood glucose management is a . . .